The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus seroprevalence

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 4, 1998, Pages 312-316

  Karstaedt, A S ^a   Jones, N ^b   Khoosal, M ^b   Crewe Brown, H H ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Diagnosis; HIV; Pulmonary; Resistance; Tuberculosis

Indexed keywords

CD4 ANTIGEN; ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CELL COUNT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG SENSITIVITY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPREVALENCE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0031961228     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Colebunders R, Ryder R, Nzilambi N, et al. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Respir Dis 1989; 139: 1082-1085.
2. Elliort A M, Luo N, Tembo G, et al. The impact of human immunodeficiency virus on tuberculosis in Zambia: a cross-sectional study. Br Med J 1990; 301: 412-415.
3. Department of Health. Tuberculosis up-date. Epidemiological Comments 1995; 22: 13-17.
4. Department of Health. Fifth National HIV survey in women attending antenatal clinics of the public health services in South Africa, October/November 1994. Epidemiological Comments 1995; 22: 90-100.
5. Githui W, Nunn P, Juma E, et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992; 73: 203-209.
6. Elliott A M, Namaambo K, Allen B W, et al. Negative sputum smear results in HIV-positive patients with pulmonary ruberculosism Lusaka, Zambia. Tubercle Lung Dis 1993;74: 191-194.
7. Gilks C F. Human immunodeficiency virus in the developing world. In: Weatherall D J, Ledingham J G G, Warrell D A eds. Oxford Textbook of Medicine, 3rd ed. Oxford: Oxford University Press 1996: 483-489.
8. Weyer K, Kleeberg H H. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement. Tubercle Lung Dis 1992; 73: 106-112.
9. Aber V, Allen B, Mitchison D, Ayuma P, Edwards E, Keyes A. Quality control in tuberculosis bacteriology. Laboratory studies in isolated positive cultures and the efficiency of direct smear examination. Tubercle 1980; 61: 123-133.
10. Roberts G D, Koneman E W, Kim K Y. Mycobacterium. In: Batows A, Hauster W J Jr, Her K L, Isenberg H D, Shadomy H J eds. Manual of Clinical Microbiology, 5th ed. Washington DC: American Society for Microbiology 1991: 304-339.
11. Hawkins J E, Wallace R J, Brown B A. Antibacterial susceptibility tests: mycobacteria. In: Balows A, Hauster W J Jr, Her K L, Isenberg H D, Shadomy H J eds. Manual of Clinical Microbiology, 5th ed. Washington DC: American Society of Microbiology 1991: 1138-1152.
12. Narain J P, Raviglione M C, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-321.
13. Bergemann A, Karstaedt A S. The spectrum of meningitis in a population with high prevalence of HIV disease. Q J Med 1996; 89: 499-504.
14. Parry C M, Kamoto O, Harries A D, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tubercle Lung Dis 1995; 76: 72-76.
15. Jones B E, Young S M M, Antoniskis D, Davidson P T, Kramer F, Barnes P. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292-1297.
16. Saunders L D, Irwig L M, Wilson T D, Kahn A, Groeneveld H. Tuberculosis management in Soweto. S Afr Med J 1984; 66: 330-342.
17. Bloch A B, Cauthen G M, Onorato I M, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
18. Braun M M, Kilburn J O, Smithwick R W, et al. HIV infection and primary resistance 10 antituberculosis drugs in Abidjan, Côte d'Ivoire. AIDS 1992; 6: 1327-1330.
19. Fischl M A, Daikos G L, Uttamchandam R B, et al. Clinical presentation and outcome of patients with HIV-infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117: 184-190.
20. The WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the World. WHO/TB/97.229. Geneva: WHO 1997.